Angelini - M&A Summary and Business Overview

Life ScienceCompany

Angelini M&A Summary

Angelini has acquired 4 companies, including 4 in the last 5 years. A total of 2 acquisitions came from private equity firms.

Angelini’s largest acquisition to date was in 2021, when it acquired Arvelle Therapeutics International for $960M. Angelini has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (67%) and consumer products (34%).

Angelini Business Overview

Where is Angelini headquartered?

Angelini is headquartered in Roma, Italy.

What sector is Angelini in?

Angelini is a life science company.

When was Angelini founded?

Angelini was founded in 1919.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 4

Angelini S.p.a.

Viale Amelia 70,
Roma, 00181
Italy,
+39 06 78053-1
www.angelinipharma.com

Angelini S.p.a. is a European player in innovation, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. Angelini S.p.a. pledge to successfully develop distinctive treatments for Mental Health conditions and Pain while selectively preserving the leading position in the Consumer Health segment.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.6/yr) # - 2 1 - - - 3
vol $960M $960M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Arvelle Therapeutics International GmbH 2021-01-05 960M USD Add-on Acquisition
Zug, Switzerland · www.arvelletx.com
ThermaCare 2020-03-07 - Divestiture
Albany, Georgia · www.thermacare.com
GlaxoSmithKline plc - ThermaCare Global Business 2020-03-07 - Divestiture
Brentford, United Kingdom
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (67%) 960M (100%) - -
Consumer Products 1 (33%) - - -
Total 3 $960M - -

By Geo

State/Country Buy Value Sell Value
Switzerland 1 960M - -
United Kingdom 1 - - -
United States 1 - - -
  Georgia 1 - - -
Domestic - - - -
Cross-border 3 (100%) 960M (100%) - -
Total 3 $960M - -

Deal Values

buy # Total
$100M to $1B 1 $960M
TOTAL $960M
Largest Arvelle Therapeutics International GmbH
$960M (2021-01-05)

M&A Connections

Deals
Acquired from
Investor(s)
33%
1 (33%)
Strategic(s)
67%
2 (67%)

 Subscribe to unlock this and 208,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Angelini

Life Science Companies , Italy Companies